AzTrials
AzTrials

Colorectal CancerPhase 2NCT00034619

A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer.

A Phase 2 study testing ALIMTA and Oxaliplatin in people with Colorectal Cancer, run by Eli Lilly and Company at 22 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to assess the antitumor activity of ALIMTA plus Oxaliplatin combination therapy in patients with previously untreated advanced colorectal cancer Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Colorectal Cancer
What is being tested?
ALIMTA and Oxaliplatin
How many people
Not given
Where
22 sitesUnited States
Study dates
Start not givento not given
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosis of primary cancer of the colon or rectum
  • Must have measurable disease
  • Must be able to comply with study procedure

Who cannot join

  • Prior chemotherapy for advanced disease
  • Pregnancy or lactation
  • Candidates for surgical resection of one or more metastatic foci
  • Second primary cancer
  • Inability to take folic acid or vitamin B12

Trial locations and contacts

22 sites in 1 country.

22 sites in 1 country

United States22 sites

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Asheville, North Carolina

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Bellevue, Washington

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Bend, Oregon

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Charleston, South Carolina

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Columbus, Ohio

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Goldsboro, North Carolina

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Hendersonville, North Carolina

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Huntsville, Alabama

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Ivins, Utah

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Kalamazoo, Michigan

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Latham, New York

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Ogden, Utah

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Philadelphia, Pennsylvania

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Pittsburgh, Pennsylvania

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Pittsfield, Massachusetts

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Portland, Oregon

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Provo, Utah

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Reading, Pennsylvania

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Seattle, Washington

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Spokane, Washington

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    St. George, Utah

  • "For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)"

    Winston-Salem, North Carolina

Other trials in United States

About this study

The purpose of this study is to assess the antitumor activity of ALIMTA plus Oxaliplatin combination therapy in patients with previously untreated advanced colorectal cancer

Being tested
ALIMTA, Oxaliplatin
Medical subject headings
Colorectal Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2002 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
IDs, dates and publications
ClinicalTrials.gov ID
NCT00034619
Sponsor's protocol ID
5142
Other IDs
H3E-MC-JMEP
Status last verified
Jul 2006
First submitted
1 May 2002
Last updated
19 Jul 2006
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing ALIMTA and Oxaliplatin in people with Colorectal Cancer, run by Eli Lilly and Company at 22 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Jul 2006. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 22 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00034619.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2006.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in